cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Beam Therapeutics Inc
95 own
24 watching
Current Price
$25.94
$0.48
(1.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,906.86M
52-Week High
52-Week High
49.50000
52-Week Low
52-Week Low
16.95000
Average Volume
Average Volume
1.13M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,906.86M
icon52-Week High49.50000
icon52-Week Low16.95000
iconAverage Volume1.13M
iconDividend Yield--
iconP/E Ratio--
What does the Beam Therapeutics Inc do?
Beam Therapeutics Inc. is a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases. Beam Therapeutics Inc.principal executive offices are located at 26 Landsdowne Street, 2nd Floor, Cambridge, MA 02139
Read More
How much money does Beam Therapeutics Inc make?
News & Events about Beam Therapeutics Inc.
Zolmax
1 year ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) has earned an average recommendation of Moderate Buy from the eleven research firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the Guggenheim 2023 ...
Zolmax
1 year ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) CFO Terry-Ann Burrell sold 47,195 shares of the companys stock in a transaction that occurred on Wednesday, January 18th. The stock was sold at an average price of $45.14, for a total value of $2,130,382.30. Following the transaction, the chief ...
Zolmax
1 year ago
Beam Therapeutics Inc. (NASDAQ:BEAM Get Rating) insider Giuseppe Ciaramella sold 51,015 shares of the firms stock in a transaction on Monday, December 12th. The shares were sold at an average price of $42.70, for a total value of $2,178,340.50. Following the completion of the sale, the insider now ...
Globe Newswire
1 year ago
Data from ESCAPE-1 and ESCAPE-2 Approaches to Be Presented During Poster Sessions at the 64th ASH Annual Meeting and ExpositionCAMBRIDGE, Mass., Dec. 10, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base ...
Frequently Asked Questions
Frequently Asked Questions
What is Beam Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Beam Therapeutics Inc shares?
plus_minus_icon
How can I buy Beam Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Beam Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Beam Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Beam Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Beam Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Beam Therapeutics Inc?
plus_minus_icon
What percentage is Beam Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Beam Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$25.94
$0.48
(1.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00